The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
Millions of Americans with obesity could soon gain access to popular weight-loss drugs including Wegovy and Ozempic through Medicare and Medicaid under a new proposal from the Biden administration ...
The Biden administration Tuesday announced plans to provide coverage for a class of costly anti-obesity medications including Wegovy and Zepbound for those enrolled in Medicare and Medicaid.
The Biden administration’s proposal to expand coverage of weight-loss drugs to Medicare and Medicaid recipients is expensive ...